Today, scientists have made a breakthrough with a new method for delivering ribonucleoprotein (RNP) complexes in vivo. Researchers have developed a “lipid nanoparticle-based RNP delivery system” which can efficiently deliver cargo RNPs into cells, tissues and organs. This technology is expected to improve the efficacy of gene therapy and provide a tool for basic research into RNP function. The lipid nanoparticle-based delivery system utilizes a liposomal formulation, which is an artificial lipid vesicle that can encapsulate therapeutic RNPs. The lipid nanoparticle-based delivery system demonstrated an enhanced efficacy in delivering RNPs in vivo compared to other conventional delivery methods. This system also demonstrated an improved ability to penetrate tissue barriers, allowing for efficient delivery of RNPs to various organs. This breakthrough is expected to have a wide range of applications in the field of gene therapy, ranging from treating genetic diseases to fighting cancer.

Read Full Article Here

source: Phys.org